A novel fibroblast growth factor-1 ligand with reduced heparin binding protects the heart against ischemia-reperfusion injury in the presence of heparin co-administration.
about
A novel fibroblast growth factor-1 ligand with reduced heparin binding protects the heart against ischemia-reperfusion injury in the presence of heparin co-administration.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A novel fibroblast growth fact ...... of heparin co-administration.
@en
A novel fibroblast growth fact ...... of heparin co-administration.
@nl
type
label
A novel fibroblast growth fact ...... of heparin co-administration.
@en
A novel fibroblast growth fact ...... of heparin co-administration.
@nl
prefLabel
A novel fibroblast growth fact ...... of heparin co-administration.
@en
A novel fibroblast growth fact ...... of heparin co-administration.
@nl
P2093
P2860
P356
P1476
A novel fibroblast growth fact ...... of heparin co-administration.
@en
P2093
Andrew Beenken
Chahua Huang
Garrett J Gross
Jo El J Schultz
Yi-Gang Wang
Zhifeng Huang
P2860
P304
P356
10.1093/CVR/CVX165
P577
2017-09-07T00:00:00Z